Table 3.
Outcome | Combined group | Transfer group | SHR (95% CI) | p-value | ||||
---|---|---|---|---|---|---|---|---|
Event | Person-years | Rate | Event | Person-years | Rate | |||
Peritonitis | 49 | 328 | 149.36 | 25 | 379 | 65.93 | 2.06 (1.23–3.46) | 0.006 |
Infection due to vascular devices, implants, and grafts | 13 | 328 | 39.63 | 27 | 379 | 71.20 | 0.46 (0.23–0.92) | 0.03 |
Infection other than peritonitis and vascular devices | 31 | 328 | 94.50 | 26 | 379 | 68.57 | 1.22 (0.66–2.26) | 0.53 |
Other complications of PD | 56 | 328 | 170.70 | 49 | 379 | 129.22 | 0.88 (0.57–1.36) | 0.56 |
Other complications of vascular devices | 23 | 328 | 70.11 | 39 | 379 | 102.85 | 0.69 (0.40–1.21) | 0.20 |
CAD | 23 | 328 | 70.11 | 18 | 379 | 47.47 | 1.52 (0.79–2.95) | 0.21 |
CAD coronary artery disease
Rate, per 1000 person-years. SHR subdistribution HR
Adjusted for age, sex, diabetes, chronic heart failure, Charlson comorbidity index, recent peritonitis, and type of vascular access for HD